HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1815875Generated: November 1, 2026
tert-Butyl 2-methyl-4-oxopiperidine-1-carboxylate → HCID 22495736, compound
https://huagongshe.com/reaction/1815875
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butyl 2-methyl-4-oxopiperidine-1-carboxylate | HCID 12992764 | — |
| Reactant | HCID 22277250 | HCID 22277250 | — |
| Reactant | HCID 178418306 | HCID 178418306 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 22495736 | HCID 22495736 | — |
Reaction Steps
A solution of 2.28 gm (9.8 mMol) 5,6-difluoro-7-bromobenzofuran in 30 mL tetrahydrofuran was cooled to −78° C. and then 9.8 mL (19.6 mMol) tert-butyllithium (1.7M in tetrahydrofuran) were added. After stirring for 30 minutes, a solution of 1.9 gm (8.9 mMol) 1-(tert-butoxycarbonyl)-2-methyl-4-oxo-piperidine in 20 mL tetrahydrofuran was added dropwise over 30 minutes. The reaction mixture was allowed to warm to room temperature over 16 hours and was then concentrated under reduced pressure. The residue was dissolved in 200 mL ethyl acetate and extracted sequentially with 50 mL 1N hydrochloric acid, saturated aqueous sodium bicarbonate, and saturated aqueous sodium chloride. The remaining organic phase was dried over magnesium sulfate and concentrated under reduced pressure to provide 1-(tert-butoxycarbonyl)-2-methyl-4-hydroxy-4-(5,6-difluorobenzofur-7-yl)piperidine. This alcohol was converted to a mixture of the title compounds essentially as described in EXAMPLE 1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06881733B1 |
|---|
| Source dataset | uspto-grants-2005_04 |
|---|
| ORD ID | ord-a0aaf7cd703b4fb6b8f28cdc972bc5e4 |
|---|
| Source note | uspto-grants-2005_04 |
|---|